INTRODUCTION
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children.
1, 2 It can be a serious and disabling condition complicated by joints destruction, growth disturbance, limb length discrepancy, osteoporosis and psychosocial problems. 3 Juvenile idiopathic arthritis is not a single disease, but a term that encompasses all forms of arthritis that begins before 16 years and persists for more than 6 weeks, and is of unknown origin. 1, 2 It is thought to have both genetic and environmental components, triggering inflammation through immune-dysregulation which is associated with alterations in both humoral and cell mediated immunity. T lymphocytes have a central role, releasing pro-inflammatory cytokines (e.g., TNF-α, IL-6, and IL-1) 4, 5 . It has heterogeneous presentation therefore, the International League of Associations for Rheumatology (ILAR) proposed different classification. 3, 6, 7 The diagnosis of JIA is based upon the pattern of symptoms; morning stiffness (>1 hour), distribution of the inflamed joints and blood and x-ray findings and exclusion of other causes. While, the management of the disease is a multidisciplinary which rely on anti-inflammatory and immune modulatory medications with physical therapy. 3, 8 The incidence, prevalence, clinical presentations vary among ethnic and geographically different population. Few Egyptian studies described the clinical profile of affected children which was our motivation to conduct this study in order to evaluate the clinical patterns of JIA, laboratory parameters and outcome of different therapeutic regimens at Alexandria governorate.
METHODS
This is an observational retrospective crosssectional study carried out at Alexandria University Children's hospital, Alexandria, Egypt. The current study was approved by local ethical committee of pediatric department and by the University Research Ethics Committee. All the medical records of the diagnosed JIA cases from January 2004 till December 2010 were checked. The cases were diagnosed according to ILAR criteria and they were followed up more than 6 months at Rheumatology Clinic. 6, 7 The collected data included: gender, age, age of first presentation, duration, clinical subtype (systemic onset arthritis, oligoarthritis or polyarthritis and arthralgia). The distribution of involved joints, main presenting features (morning stiffness, intermittent fever, skin rash, pallor, lymphadenopathy, hepato-splenomegaly, uveitis, pericardial effusion or valve damage). Results of laboratory data of CBC, CPR, erythrocyte sedimentation rate, rheumatoid factor (RF), antinuclear antibody (ANA). Results of Slit lamp examinations, chest x ray and echocardiography. Also, the study assessed different therapeutic protocols including: Single drug regimen (Prednisone, methotrexate or naproxen), double regimen (methotrexate with any of the previous drugs) and triple regimen as well as the outcome of disease whether remittent or unremittent. The disease course was considered remittent if disease activity lasted less than 2 years from the onset and terminated in remission without recurrence, while progressive or unremitting disease course was characterized by active disease for more than two years.
9
Pilot study: A pilot study was conducted. in order to fulfill the pilot study, a sample of 5 files of cases was chosen randomly. From the pilot study, the following points have been raised: a. The Pediatric Rheumatology Clinic of the Children's Hospital, Alexandria University, was a suitable place for the research.
b. The researcher can carry out data collection skillfully and with confidence.
Analysis of data:
The results were checked. Then, the data were entered into SPSS system files (SPSS package version 18) 
RESULTS
The current study included 63 patients with mean age of 7.3 y ±3.1 (ranged from 3.8y to 16 y) at study time however, the mean age at diagnosis was 6.1±2.8 (ranged between 3 y and 14 y). About 57.1% of the cases were from rural areas (mostly oligoarticular subtype) while 42.9% were from urban areas with highly significant differences to rural areas (p=0.018). Positive family history of JIA was reported among 30.2% of cases as summarized in table (1) . Table ( 2) showed the spectrum of clinical patterns of JIA in our study in which oligoarticular subtype were the predominant (41.2%) followed by polyarticular (35%) then systemic onset type in (23.8%) with no other subtypes. In oligoarticular onset JIA, 2 subtypes were detected, persistent oligoarticular arthritis, which was present in 77.0 % and extended oligoarticular arthritis which occurred in 33% of cases.
The current study included 33 males and 30 females, at 1.1:1 ratio. However, there was a female predominance in the oligoarticular (57.7%) and the systemic onset subtypes (53,4%) in comparison to polyarthritis which showed male predominance (68%) but with no significant difference. (tables 1, 2) Table ( 3) showed the distribution of involved joints in different subtypes. Knee joint was the most frequently affected in oligoarticular subtype (84.3%) while wrist (86.4%) and ankle were mostly encountered in the polyarticular and systemic onset respectively. The results showed highly significant difference between the studied subtypes as regards affection of the wrist joint (p=0.011), the elbow joint (p=<0.0001), cervical joint (p=0.001), sacroiliac joint (0.002), MTPS (p=0.014), PIPS (p=0.0002) and MCPS (p=<0.0001) in polyarticular type when compared to other subtypes. Meanwhile, no statistically significant differences in affection of the knee, the ankle, the hip and the shoulder joints between the subtypes.
Regarding the clinical characteristics of children, table (3, 4) summarized that as it revealed highly significant difference between the studied subtypes as regards the intermittent fever (p=<0.0001), skin rash (p=<0.0001), lymphadenopathy (p=0.008), hepatosplenomegaly (p=0.008) and cardiac involvement (valve damage or pericardial effusion) (p=0.001) to systemic onset JIA rather than the other subtypes. While, the results showed no statistically significant differences regarding morning stiffness, pallor, uveitis, pleuritic, renal, skin, GIT involvements, oral and CNS disease between the three studied subtypes.
Table (5) presented the results of main laboratory investigations. Anemia, leukocytosis, thrombocytopenia, elevated first hour ESR, and CRP were common finding at presentation but without significant difference among the subgroups. The results detected that the difference in raised second hour of ESR was significant high (p=0.018) in polyarticular type when compared to others. Also, difference in the percent of positive RF cases and ANA positive cases ((p=0.0001, p=0.007) were significantly higher in oligoarticular type.
The difference in the percent of cases with positive RF was statistically significant higher among unremitting groups when compared to remitting group (p = 0.003). Meanwhile our results showed no statistically differences between remitting and unremitting groups as regards number of ANA positive cases as in table (6) .
Lastly, the outcome of the disease was displayed at table (1) . In general, disease remission was achieved among 30 cases out of 63 (47.4%) which were mostly (46.3%) among persistent oligoarthritis. Table (7) summarized the relation of remission to the drug regimen as it revealed that the difference in percent of remittent cases who were on tow drug regimen was statistical a significant higher (P=0.035*) when compared to single drug users (53.6% versus 20.1%).
However, no significant difference between remitted cases on double and triple therapy. It is characterized by chronic synovitis of peripheral joints manifested as soft tissue swelling and effusion. In the current study, medical records of sixty-three children at the pediatric rheumatology clinic were retrospectively analyzed. Similar to previous studies mainly in USA, Canada, Turkey, France and Spain oligoarticular JIA was found to be the most common clinical pattern. 11, 12 On contrary to Saudi Arabia study 13 , systemic onset was the most common type while a Kuwaiti study conducted by Khuffash 14 
.3%, 52.2%, respectively) because of variability of environmental and genetic factors. 15, 16 Most of the demographic data of the studied groups were consistent with results of previous national and international studies as the mean age of onset of the disease was (6.1±2.8 yr.), which was close to that reported in Saudi Arabia (6± 2 yr.) by Bahabri et al 12 and Mengual et al 17 in Spain (5.8±2.2 yr.). Meanwhile, age was lower than that reported by Ruperto et al 18 (8±3yr) and a cohort study at Taiwan (9.1y).
19 Also, the current study reported that most of the cases were from rural areas similar to Quartier et al 10 and Abu elsoud et al. 16 Family history of JIA showed high frequency among patients like other studies. 15, 20 On contrary, to many studies the numbers of male patients were higher than the females. [11] [12] [13] [14] [15] [16] However, our results matched Ozdogan et al 21 and El-hemiari et al 22 who reported male predominance.
The Clinical profile of different subtypes of JIA was comparable to those reported in literature. knee joints were the predominately involved in oligoarticular JIA while wrist, elbow, sacroiliac joints and small joints of hand showed higher significant difference to poly articular subtype. Similar to the results reported by Viswanathakumar et al 23 (Indian study). Our results were contradictory to Bahabri et al 13 who concluded that knee joint was the least involved and this may be because the systemic onset subtype was the predominant type among Saudi children with common involvement of wrist or ankle joints.
Despite that morning stiffness was the most common presenting symptom among all subtypes, fever, skin rash, lymphadenopathy, hepatosplenomegaly and cardiac involvement showed higher significant difference to systemic onset JIA group. This was agreed by Grassi et al, 24 Chandrasekaran et al 25 and Salah et al. 15 Our study reported that pallor was the predominant extraarticular manifestations (42.2% 21 reported lower results (12%, 5%) respectively. The higher percentage of positive ANA results could be attributed to higher incidence of infections inducing the illness. About 30.3% of ANA positive cases developed uveitis. Regarding other laboratory results, ESR was the most frequent raised laboratory result in all subgroups, followed by positive rheumatoid factor specially among oligoarticular subtype. Our results were nearly equal to those found in other studies. 14, 20, 27 Most of anemic patients were of polyarticular subtype near to results of Baharbi et al. 13 Meanwhile, most of CRP positive cases were of systemic onset subtype as reported by Italian study done by Melano in 2007. 29 The management of JIA aimed to control active symptoms, achieve remission and to prevent joint damage. Since the introduction of biologic agents such as methotrexate major advances has been achieved however, non-steroidal anti-inflammatory drugs (NSAIDs) are the mainstay of treatment. Glucocorticoids have been used usually for severe life-threatening disease, or rapidly progressive disease and uveitis. In the current study the patient outcomes and rate of remission were variable throughout the three subtypes.
The current study showed global remission rate of 47.6% among all cases. Meanwhile, the highest remission rate was observed among patients suffering from oligoarthritis followed by polyarthritis and lastly among systemic onset cases. Similar to remission rates recorded by Salah et al 15 and Khufash et al 14 (about 54%). Meanwhile, other studies reported lower rates (as 29.4%) 13, 21 . This variability in the relative frequency of the remission rate may be due to differences in environmental and genetic factors, with possible exposure to different types of infections and being subjected to different therapeutic regimens and or to the positivity of rheumatoid factor. 30 The highest remission rate (53.2%)was found among patients who received two drugs regimen. Similar remission rate was reported by many studies 10, 14 specially Sircar et al 31 (51%) however, Weiss et al had reported higher remission rate (79%). 32 Cases who used single drug regimen either prednisone or methotrexate and or naproxen showed lower remission rate (20.1%) in agreement to other studies. 33 No significant difference of triple therapy to double therapy on the course of the disease matched to results found by Ozdogan et al and Quartier et al. 10, 21 Table (8) showed the epidemiological data in the three Egyptian studies -conducted in 3 governorates -including the present one.
CONCLUSION
The characteristics of JIA in Egyptian children at different areas are comparable to each other with higher frequency of oligoarticular subtype disease specially for rural areas. The discrepancies between the pattern of the disease in Egypt and those reported from Arabian Gulf countries and Western countries may be related to different immunogenic background of different ethnic groups, a point that needs further studies.
Future studies are necessary to clarify the role of other therapeutic alternatives in treatment and to elucidate the implications of different therapeutic regimens on long term morbidity and mortality.
